This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishikawa, M. Articles by Kerbel, R. S. Search for Related Content PubMed PubMed Citation Articles by Ishikawa, M. Articles by Kerbel, R. S.

Isolation and Characterization of Spontaneous Wheat Germ Agglutinin-resistant Human Melanoma Mutants Displaying Remarkably Different Metastatic Profiles in Nude Mice¹

Division of Cancer and Cell Biology, Mt. Sinai Hospital Research Institute, Toronto, Ontario, Canada M5G 1X5, and the Department of Medical Genetics, University of Toronto, Toronto, Ontario, Canada

Spontaneous wheat germ agglutinin (WGA)-resistant mutants of the MeWo human malignant melanoma line were isolated after sequential selection in increasingly toxic concentrations of WGA, without prior mutagenesis. They were isolated in an attempt to obtain "membrane glycosylation mutants" having significantly altered metastatic properties when grown in nude mice, and to characterize the biochemical (oligosaccharide) changes associated with altered metastatic behavior. The lines were assessed for their sensitivity to other lectins, membrane glycoprotein profiles, ploidy levels, and their ability to produce "artificial" metastases in nude mice after i.v. inoculation. One mutant, called 70-W, manifested a 3- to 4-fold resistance to WGA compared with wild-type cells. When inoculated into NIH Swiss nude mice, 70-W cells not only produced extensive lung colony formation but also showed an extraordinary ability to disseminate widely and extensively in a clinical fashion to many extrapulmonary sites such as the subcutis, mesentery, muscle, and brain. Moreover the majority of these metastases were deeply pigmented facilitating visual identification of very small visceral metastases. A second mutant called 3S5 was isolated and found to be highly resistant to WGA (>20-fold resistance). This line was virtually devoid of metastatic ability and was found by biochemical analysis to be phenotypically similar to the class I WGA resistant non-metastatic mutants previously isolated from the highly metastatic murine tumor MDAY-D2 which are known to be deficient in sialic acid and galactose. The similarity between these and earlier results using lectin resistant mutant rodent cell lines strongly suggests that sialylated glycoconjugates contribute to the metastasis of both animal and human tumors of different tissue origin. These new spontaneously derived WGA resistant MeWo mutants should be valuable new tools for the study of human tumor progression in vivo and factors involved in metastasis, especially the contribution of oligosaccharide moieties of cell surface glycoconjugates.

¹ This work was supported primarily by a grant (R01-CA-41233) from NIH and by a grant from the National Cancer Institute of Canada.

² Research Scholar of the National Cancer Institute of Canada.

³ Research Associate of the National Cancer Institute of Canada. To whom requests for reprints should be addressed.

Received 8/20/87. Revised 10/23/87. Accepted 10/29/87.

This article has been cited by other articles:

				A. A. Mourad-Zeidan, V. O. Melnikova, H. Wang, A. Raz, and M. Bar-Eli Expression Profiling of Galectin-3-Depleted Melanoma Cells Reveals its Major Role in Melanoma Cell Plasticity and Vasculogenic Mimicry Am. J. Pathol., December 1, 2008; 173(6): 1839 - 1852. [Abstract] [Full Text] [PDF]

				Y. Denkins, J. Reiland, M. Roy, N. D. Sinnappah-Kang, J. Galjour, B. P. Murry, J. Blust, R. Aucoin, and D. Marchetti Brain metastases in melanoma: Roles of neurotrophins Neuro-oncol, April 1, 2004; 6(2): 154 - 165. [Abstract] [PDF]

				C. Tellez, M. McCarty, M. Ruiz, and M. Bar-Eli Loss of Activator Protein-2{alpha} Results in Overexpression of Protease-activated Receptor-1 and Correlates with the Malignant Phenotype of Human Melanoma J. Biol. Chem., November 21, 2003; 278(47): 46632 - 46642. [Abstract] [Full Text] [PDF]

				D. E. Goertz, J. L. Yu, R. S. Kerbel, P. N. Burns, and F. S. Foster High-Frequency Doppler Ultrasound Monitors the Effects of Antivascular Therapy on Tumor Blood Flow Cancer Res., November 15, 2002; 62(22): 6371 - 6375. [Abstract] [Full Text] [PDF]

				D. Jean, M. Harbison, D. J. McConkey, Z. Ronai, and M. Bar-Eli CREB and Its Associated Proteins Act as Survival Factors for Human Melanoma Cells J. Biol. Chem., September 18, 1998; 273(38): 24884 - 24890. [Abstract] [Full Text] [PDF]

				J. Dong, P. Lamb, C. Rinker-Schaeffer, J Vukanovic, T Ichikawa, J. Isaacs, and J. Barrett KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 Science, May 12, 1995; 268(5212): 884 - 886. [Abstract] [PDF]